ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 100 filers reported holding ATRECA INC in Q4 2021. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $39,150 | -73.4% | 150,000 | 0.0% | 0.00% | -75.0% |
Q2 2023 | $147,000 | +28.9% | 150,000 | +50.0% | 0.00% | +33.3% |
Q1 2023 | $114,000 | +42.4% | 100,000 | 0.0% | 0.00% | +50.0% |
Q4 2022 | $80,060 | -49.0% | 100,000 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $157,000 | -12.3% | 100,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $179,000 | -43.5% | 100,000 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $317,000 | -19.5% | 100,000 | -23.1% | 0.01% | -14.3% |
Q4 2021 | $394,000 | -58.2% | 130,000 | -14.0% | 0.01% | -61.1% |
Q3 2021 | $942,000 | – | 151,200 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,320,880 | $2,100,000 | 1.66% |
CM Management, LLC | 249,282 | $391,000 | 0.44% |
Aisling Capital Management LP | 387,653 | $609,000 | 0.40% |
Boxer Capital, LLC | 2,202,333 | $3,458,000 | 0.19% |
Samsara BioCapital, LLC | 396,835 | $623,000 | 0.14% |
Redmile Group, LLC | 800,306 | $1,256,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 191,442 | $301,000 | 0.04% |
Baker Brothers Advisors | 3,532,760 | $5,546,000 | 0.04% |
Cormorant Asset Management, LP | 319,057 | $501,000 | 0.04% |
Rock Springs Capital Management LP | 462,530 | $726,000 | 0.02% |